Tom McCourt, Ironwood CEO

Iron­wood to buy Vec­tivBio in $1B all-cash deal to ex­pand rare gas­troin­testi­nal pipeline 

Iron­wood Phar­ma­ceu­ti­cals agreed to buy Swiss biotech Vec­tivBio in an all-cash deal with an es­ti­mat­ed ag­gre­gate con­sid­er­a­tion of about $1 bil­lion, ex­tend­ing the “

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.